These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30228642)

  • 21. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
    Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
    J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.
    Clifton MM; Johnson SM; Roberson PK; Kincannon J; Horn TD
    Pediatr Dermatol; 2003; 20(3):268-71. PubMed ID: 12787281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
    Nofal A; El-Arab RE; Nasr M; Alakad R
    J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candida immunotherapy of warts.
    Signore RJ
    Arch Dermatol; 2001 Sep; 137(9):1250-1. PubMed ID: 11559230
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of doughnut warts with intralesional Candida antigen immunotherapy.
    Nofal A; Fouda I; Aboelwafa H; Fawzy MM
    J Cosmet Dermatol; 2021 Jan; 20(1):295-299. PubMed ID: 32432375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Goodbye warts, hello vitiligo: Candida antigen-induced depigmentation.
    Wilmer EN; Burkhart CN; Morrell DS
    Pediatr Dermatol; 2013; 30(6):e214-5. PubMed ID: 23252470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.
    Johnson SM; Horn TD
    J Drugs Dermatol; 2004; 3(3):263-5. PubMed ID: 15176159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mannose binding lectin in response to candida antigen immunotherapy of warts.
    Nasr M; Marie A; Boghdadi G; Elsaid R; Salah E
    J Dermatolog Treat; 2021 Jun; 32(4):376-380. PubMed ID: 31469597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year experience with candida antigen immunotherapy for warts and molluscum.
    Maronn M; Salm C; Lyon V; Galbraith S
    Pediatr Dermatol; 2008; 25(2):189-92. PubMed ID: 18429776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intralesional immunotherapy with Candida antigen for the treatment of molluscum contagiosum in children.
    Enns LL; Evans MS
    Pediatr Dermatol; 2011; 28(3):254-8. PubMed ID: 21615471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts.
    Nofal A; Yehia E; Khater E; Bessar H
    J Am Acad Dermatol; 2020 Jul; 83(1):208-210. PubMed ID: 32006600
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of intralesional Candida antigen in diabetic patients with multiple warts.
    Marei A; Alakad R; Wahid RM
    J Cosmet Dermatol; 2021 Apr; 20(4):1248-1253. PubMed ID: 32924256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional Candida antigen versus intralesional tuberculin in the treatment of recalcitrant genital warts: A comparative study.
    Nofal A; Soliman M; Hamdy F; Alakad R
    J Am Acad Dermatol; 2020 Jun; 82(6):1512-1514. PubMed ID: 31923442
    [No Abstract]   [Full Text] [Related]  

  • 34. The effectiveness of intralesional Candida antigen immunotherapy as a treatment for anogenital warts: a retrospective chart review.
    Logel M; Pammett R; Chiang C; O'Toole A; Gooderham M
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e142-e145. PubMed ID: 34553430
    [No Abstract]   [Full Text] [Related]  

  • 35. The status of immunotherapy in the United States, 2002.
    Silverberg NB
    Cutis; 2002 Sep; 70(3):155-6. PubMed ID: 12353888
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulsed-dye laser versus intralesional Candida albicans antigen injection in treatment of genital warts.
    Elmaadawy EH; Shams SS; Hegab DS; Zaki RA
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Mar; 28(1):21-26. PubMed ID: 30901065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
    Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
    Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement component 3c and tumor necrosis factor-α systemic assessment after Candida antigen immunotherapy in cutaneous warts.
    Hammad NM; Abdelhadi AA; Fawzy MM; Marei A
    Braz J Microbiol; 2020 Dec; 51(4):1673-1681. PubMed ID: 32594377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The painful purple digit: an alarming complication of Candida albicans antigen treatment of recalcitrant warts.
    Perman M; Sterling JB; Gaspari A
    Dermatitis; 2005 Mar; 16(1):38-40. PubMed ID: 15996350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
    Abdel Razik LH; Obaid ZM; Fouda I
    J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.